| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/28/2011 | WO2011050222A2 Therapeutic compositions that disrupt the hydrogen bonded ring structure in gp41 and methods for treating hiv |
| 04/28/2011 | WO2011050199A1 Methods and compositions for panic disorders |
| 04/28/2011 | WO2011050194A1 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein |
| 04/28/2011 | WO2011050173A1 Methods, kits and reaction mixtures for analyzing single-stranded nucleic acid sequences |
| 04/28/2011 | WO2011050172A1 Antibodies, systems and methods for determining relative hemolytic index |
| 04/28/2011 | WO2011050153A1 Motion of a chiral object |
| 04/28/2011 | WO2011050134A2 Detection and treatment of lrp4-associated neurotransmission disorders |
| 04/28/2011 | WO2011050103A1 Method of using non-rare cells to detect rare cells |
| 04/28/2011 | WO2011050096A2 Methods and compositions for diagnosis and treatment of genetic and retinal disease |
| 04/28/2011 | WO2011050076A1 Methods and systems for pre-conceptual prediction of progeny attributes |
| 04/28/2011 | WO2011050070A1 Liquid drop diagnostic assays |
| 04/28/2011 | WO2011050069A1 Proximity-mediated assays for detecting oncogenic fusion proteins |
| 04/28/2011 | WO2011050052A2 Protein agent for diabetes treatment and beta cell imaging |
| 04/28/2011 | WO2011050039A2 Modular functional peptides for the intracellular delivery of nanoparticles |
| 04/28/2011 | WO2011050027A2 Surface-assisted hemagglutination and hemagglutination inhibition assays |
| 04/28/2011 | WO2011050004A1 Nonvisual indication of an unwanted chemical in an ingestible substance |
| 04/28/2011 | WO2011049969A2 Synergistic interactions of phenolic compounds found in food |
| 04/28/2011 | WO2011049961A2 Compositions and methods for imaging cells |
| 04/28/2011 | WO2011049955A1 Deducing exon connectivity by rna-templated dna ligation/sequencing |
| 04/28/2011 | WO2011049822A2 Patterned chemical sensor having inert occluding layer |
| 04/28/2011 | WO2011049758A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | WO2011049718A1 Electrokinetic microfluidic flow cytometer apparatuses with differential resistive particle counting and optical sorting |
| 04/28/2011 | WO2011049645A1 Tivozanib response prediction |
| 04/28/2011 | WO2011049603A1 Biomarkers to identify hiv-specific t-cell subsets |
| 04/28/2011 | WO2011049601A2 Piezoelectric coagulation sensors |
| 04/28/2011 | WO2011049530A1 Method for determination of macromolecular multimers |
| 04/28/2011 | WO2011049448A1 Methods for diagnosis of immune responses against viruses |
| 04/28/2011 | WO2011049442A2 Blood coagulation status measurement in saliva |
| 04/28/2011 | WO2011049433A1 Diagnosis and treatment of pruritis |
| 04/28/2011 | WO2011049431A1 Blood coagulation status measurement in saliva |
| 04/28/2011 | WO2011049412A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 04/28/2011 | WO2011049264A1 Amphiphilic peptide promoting the formation of a target mirna, and method for controlling the formation of the target mirna using same |
| 04/28/2011 | WO2011049239A1 Human erosive rheumatoid arthritis model non-human mammal |
| 04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
| 04/28/2011 | WO2011049044A1 Biosensor using magnetic microparticles |
| 04/28/2011 | WO2011049043A1 Screening method utilizing thalidomide-targeting factor |
| 04/28/2011 | WO2011048922A1 Method for detection of glycosaminoglycan, and molecular probe for use in the method |
| 04/28/2011 | WO2011048561A1 Diagnostic and therapeutic methods for rheumatic heart disease based upon group a streptococcus markers |
| 04/28/2011 | WO2011048536A1 Method and apparatus for measuring the concentration of a gas in exhaled air |
| 04/28/2011 | WO2011048448A1 Animal model for cigarette smoke-induced atherosclerosis and related methods |
| 04/28/2011 | WO2011048381A1 Test device and method |
| 04/28/2011 | WO2011048369A1 Prognostic, screening and treatment methods and agents for treatment of metastasis and inflammation using t54 oncofoetal glycoprotein |
| 04/28/2011 | WO2011048173A1 Mcam as a biomarker for fluid homeostasis |
| 04/28/2011 | WO2011048168A1 Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
| 04/28/2011 | WO2011048147A1 Method for measuring the cloudiness of paints on test tables |
| 04/28/2011 | WO2011048116A1 Method for the differentiation between patients with active ulcerative colitis and patients in remission by detecting volatile organic compounds in exhaled air |
| 04/28/2011 | WO2011048115A1 Method for the differentiation between patients with active crohn's disease and patients in remission by detecting volatile organic compounds in exhaled air. |
| 04/28/2011 | WO2011048114A1 Method for the differentiation between crohn's disease and ulcerative colitis by detecting volatile organic compounds in exhaled air |
| 04/28/2011 | WO2011048113A1 Method for the diagnosis of inflammatory bowel disease by detecting volatile organic compounds in exhaled air |
| 04/28/2011 | WO2011048080A1 3-nitrotyrosinated fibrinogen as a diagnostic marker in ischemic stroke and uses thereof |
| 04/28/2011 | WO2011048044A1 System for determining unprocessed and partially processed neurotoxin type a |
| 04/28/2011 | WO2011048043A1 NON-CROSS-REACTIVE ANTI IgG ANTIBODIES |
| 04/28/2011 | WO2011047870A1 Nested cell encapsulation |
| 04/28/2011 | WO2011047813A1 Self cleaning optical probe |
| 04/28/2011 | WO2011047688A1 Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in prostate cancer. |
| 04/28/2011 | WO2011047680A1 Immunochemical detection of single target entities |
| 04/28/2011 | WO2011047671A1 Biopsy instrument comprising a magnetic element |
| 04/28/2011 | WO2011047399A1 Process for quantitative determination of emissions, consisting of particulate matter, from surfaces of flexible sheet-like materials and device therefore |
| 04/28/2011 | WO2011027979A3 Biosensor capable of automatically recognizing codes and code recognition method using the same |
| 04/28/2011 | WO2011027146A3 Ultrasound & magnetic method |
| 04/28/2011 | WO2011026122A3 B7-h4 fusion proteins and methods of use thereof |
| 04/28/2011 | WO2011018618A3 Assay device |
| 04/28/2011 | WO2011017077A3 Nanochannel-based sensor system with controlled sensitivity |
| 04/28/2011 | WO2011014721A3 Genetically modified rat models for pharmacokinetics |
| 04/28/2011 | WO2011013112A3 Phase behavior analysis using a microfluidic platform |
| 04/28/2011 | WO2011011114A3 Pharmaceutical packaging and method for delivery of same |
| 04/28/2011 | WO2011009077A3 Labeled skin lesion biopsy punch and uses thereof |
| 04/28/2011 | WO2011006011A3 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates |
| 04/28/2011 | WO2010148135A3 Harvesting target materials from centrifuged suspensions |
| 04/28/2011 | WO2010144846A3 Gastrointestinal disease or disorder imaging and treatment |
| 04/28/2011 | WO2010141719A3 Materials and methods for measuring nitric oxide levels in a biological fluid |
| 04/28/2011 | WO2010135475A3 Phosphorylated fatty acid synthase and cancer |
| 04/28/2011 | WO2010123283A3 Fluorescently marked cohesin marker, and a cellulosome-forming-enzyme detection method employing the same |
| 04/28/2011 | WO2010102070A8 Methods of treating hpv-associated cancer with jnk inhibitors |
| 04/28/2011 | WO2010041231A9 Cell sorting device |
| 04/28/2011 | WO2010034519A3 Synergistic peroxide based biocidal compositions |
| 04/28/2011 | US20110099647 Antibodies against cd38 for treatment of multiple myeloma |
| 04/28/2011 | US20110099644 Mig-6 knockout mice and elucidation of association of mig-6 with early onset degenerative joint disease and role as a tumor suppressor |
| 04/28/2011 | US20110098936 Method for determining the heating value and the relative density of a hydrocarbon fuel and apparatus for the same |
| 04/28/2011 | US20110098541 Method and apparatus for penetrating tissue |
| 04/28/2011 | US20110098447 Homogenous Populations of Molecules |
| 04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| 04/28/2011 | US20110098353 Compounds for Imaging and Therapy |
| 04/28/2011 | US20110098339 C2orf18 as target gene for cancer therapy and diagnosis |
| 04/28/2011 | US20110098326 2-fluorothiazole derivatives useful as imaging agents; methods of synthesis, and methods of use |
| 04/28/2011 | US20110098306 Uses of tetrahydrobiopterin, sepiapterin and derivatives thereof |
| 04/28/2011 | US20110098281 Benzenesulfonyl Compounds and the Use Thereof |
| 04/28/2011 | US20110098276 Oxycarbamoyl compounds and the use thereof |
| 04/28/2011 | US20110098243 Ectonucleotidase pyrophosphate/phosphodiesterase-1 (enpp-1) as a target for the treatment of aortic valve stenosis and cardiovascular calcification |
| 04/28/2011 | US20110098242 Methods and Compositions for Diagnosing and Treating Cervical Intraepithelial Neoplasia and Cervical Cancer |
| 04/28/2011 | US20110098234 Breast cancer proteins |
| 04/28/2011 | US20110098227 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 04/28/2011 | US20110098218 Modulators of stat3 signalling |
| 04/28/2011 | US20110098215 Peptides and methods of use as therapeutics and screening agents |
| 04/28/2011 | US20110098214 Lps or lipid a binding agent and novel peptide |
| 04/28/2011 | US20110098212 Cytokine |
| 04/28/2011 | US20110098211 Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
| 04/28/2011 | US20110098201 Arrays of microparticles and methods of preparation thereof |
| 04/28/2011 | US20110098192 Methods for assessing liver pathologies |
| 04/28/2011 | US20110098191 In vitro methods for detecting renal cancer |